<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:e sem="disease" ids="C0038436" disease_type="Mental or Behavioral Dysfunction" abbrv="PTSD">Posttraumatic stress disorder (PTSD)</z:e> prospectively increases the risk of incident <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) independent of other risk factors in otherwise healthy individuals </plain></SENT>
<SENT sid="1" pm="."><plain>Between 10% and 20% of patients develop <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> related to the traumatic experience of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (MI) </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the hypothesis that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> symptoms caused by MI predict adverse cardiovascular outcome </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We studied 297 patients (61 ± 10 years, 83% men) who self-rated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> symptoms attributable to a previous index MI </plain></SENT>
<SENT sid="4" pm="."><plain>Non-fatal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-related hospital readmissions (i.e. recurrent MI, elective and non-elective intracoronary stenting, bypass surgery, pacemaker implantation, <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo>, cerebrovascular event) were assessed at follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>Cox proportional hazard models controlled for demographic factors, <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> severity, major <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk factors, cardiac medication, and mental health treatment </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Forty-three patients (14.5%) experienced an adverse event during a mean follow-up of 2.8 years (range 1.3-3.8) </plain></SENT>
<SENT sid="7" pm="."><plain>A 10 point higher level in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> symptom score (mean 8.8 ± 9.0, range 0-47) revealed a hazard ratio (HR) of 1.42 (95% CI 1.07-1.88) for a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-related hospital readmission in the fully adjusted model </plain></SENT>
<SENT sid="8" pm="."><plain>A similarly increased risk (HR 1.45, 95% CI 1.07-1.97) emerged for patients with a major or unscheduled <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-related readmission (i.e. when excluding patients with elective stenting) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Elevated levels of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> symptoms caused by MI may adversely impact non-fatal cardiovascular outcome in <z:e sem="disease" ids="C0856742" disease_type="Disease or Syndrome" abbrv="">post-MI</z:e> patients independent of other important prognostic factors </plain></SENT>
<SENT sid="10" pm="."><plain>The possible importance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> symptoms as a novel prognostic psychosocial risk factor in <z:e sem="disease" ids="C0856742" disease_type="Disease or Syndrome" abbrv="">post-MI</z:e> patients warrants further study </plain></SENT>
</text></document>